Jonathan Silverstein Insider Profile
4 Followers
Jonathan Silverstein, Director, Ten Percent Owner at Arcutis Biotherapeutics, holds 902.29K shares in Arcutis Biotherapeutics (Ticker: ARQT), holds 0.00 shares in Avedro (Ticker: ~AVDR), holds 0.00 shares in Glaukos (Ticker: GKOS). Most recently, Jonathan Silverstein Bought ― shares of Arcutis Biotherapeutics on Oct 06, 2020 for an estimated value of $12.40M.
Jonathan Silverstein's Trading History
| ARQTArcutis Biotherapeutics | Oct 06, 2020 | Director, Ten Percent Owner | Informative Buy | 12.40M | $25.50M | |
| ~AVDRAvedro | Nov 25, 2019 | ― | Uninformative Sell | ― | $0.00 | |
| GKOSGlaukos | Mar 06, 2018 | Director | Informative Sell | 26.79M | $0.00 | |
| ACETAdicet Bio | Jan 30, 2018 | Director | Uninformative Buy | ― | $13.43M | |
| SCPHscPharmaceuticals | Nov 21, 2017 | ― | Uninformative Buy | ― | $14.61M | |
| ICPTIntercept Pharma | Nov 27, 2015 | ― | Uninformative Buy | ― | $21.31M | |
| ROKASorrento Tech Inc | Jul 24, 2014 | ― | Uninformative Buy | ― | $19.75K | |
| RLYPRelypsa Inc | Nov 20, 2013 | ― | Uninformative Sell | 300.10K | $318.03M | |
| AVNRAvanir Pharmaceuticals | ― | ― | ― | ― | ||
| PODDInsulet | ― | Director | ― | $239.22M | ||
| NXTMNxStage Medical | ― | ― | ― | $166.67M |
You May Also Like
Jonathan Silverstein insider profile FAQ
What is the percentage of profitable transactions made by Jonathan Silverstein?
The percentage of profitable transactions made by Jonathan Silverstein is 41%.
What is the average return per transaction made by Jonathan Silverstein?
The average return per transaction made by Jonathan Silverstein is -8.50%.
What stocks does Jonathan Silverstein hold?
Jonathan Silverstein holds: ARQT, ICPT, GKOS, SCPH, ACET, ~AVDR, ROKA, RLYP, NXTM, PODD, AVNR stocks.
What was Jonathan Silverstein’s latest transaction?
Jonathan Silverstein’s latest transaction was an Informative Buy of $12.40M.
What was Jonathan Silverstein's most profitable transaction?
Jonathan Silverstein’s most profitable transaction was an Informative Sell of ICPT stock on March 30, 2015. The return on the trade was 57.70%.
What is Jonathan Silverstein's role in Arcutis Biotherapeutics?
Jonathan Silverstein's role in Arcutis Biotherapeutics is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
